Standard BioTools Inc. is a global enterprise dedicated to the development, production, and distribution of sophisticated instruments, expendable supplies, specialized chemical reagents, and software solutions for both scientific research and clinical diagnostic laboratories worldwide. The company's comprehensive product lineup features advanced analytical platforms such as the Helios CyTOF system, alongside Hyperion imaging systems, Hyperion tissue imagers, and flow conductors. To support biological investigations, they provide a range of assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits, particularly valuable in immuno-oncology research. Their offerings also encompass preparatory instrumentation like the Juno systems, as well as high-performance analytical systems such as the Biomark HD system and EP1 system. A core element of their technology involves integrated fluidic circuits (IFCs), available in multiple configurations including library preparation IFCs, Juno genotyping IFCs, dynamic array IFCs, digital array IFCs, and Flex Six IFCs. Complementing these, they offer an extensive array of assays and reagents, spanning Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers, targeted sequencing prep primers, and targeted DNA Seq library assays. Furthermore, Standard BioTools specializes in single-cell microfluidics with its C1 systems and corresponding C1 IFCs, augmented by various software solutions. Their diverse customer base includes academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, biopharmaceutical and biotechnology companies, plant and animal research organizations, and contract research organizations. The company holds significant license agreements with esteemed institutions such as the California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. Established in 1999 under its initial name, Mycometrix Corporation, the firm rebranded to Fluidigm Corporation in April 2001 and maintains its headquarters in South San Francisco, California.